Your browser doesn't support javascript.
loading
Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images.
Veiga-Canuto, Diana; Cerdà-Alberich, Leonor; Jiménez-Pastor, Ana; Carot Sierra, José Miguel; Gomis-Maya, Armando; Sangüesa-Nebot, Cinta; Fernández-Patón, Matías; Martínez de Las Heras, Blanca; Taschner-Mandl, Sabine; Düster, Vanessa; Pötschger, Ulrike; Simon, Thorsten; Neri, Emanuele; Alberich-Bayarri, Ángel; Cañete, Adela; Hero, Barbara; Ladenstein, Ruth; Martí-Bonmatí, Luis.
Afiliação
  • Veiga-Canuto D; Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
  • Cerdà-Alberich L; Área Clínica de Imagen Médica, Hospital Universitario y Politécnico La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
  • Jiménez-Pastor A; Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
  • Carot Sierra JM; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, 46026 Valencia, Spain.
  • Gomis-Maya A; Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Camí de Vera s/n, 46022 Valencia, Spain.
  • Sangüesa-Nebot C; Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
  • Fernández-Patón M; Área Clínica de Imagen Médica, Hospital Universitario y Politécnico La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
  • Martínez de Las Heras B; Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
  • Taschner-Mandl S; Unidad de Oncohematología Pediátrica, Hospital Universitario y Politécnico La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
  • Düster V; St. Anna Children's Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, Austria.
  • Pötschger U; St. Anna Children's Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, Austria.
  • Simon T; St. Anna Children's Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, Austria.
  • Neri E; Department of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, 50937 Cologne, Germany.
  • Alberich-Bayarri Á; Academic Radiology, Department of Translational Research, University of Pisa, Via Roma, 67, 56126 Pisa, Italy.
  • Cañete A; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, 46026 Valencia, Spain.
  • Hero B; Unidad de Oncohematología Pediátrica, Hospital Universitario y Politécnico La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
  • Ladenstein R; Department of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, 50937 Cologne, Germany.
  • Martí-Bonmatí L; St. Anna Children's Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, Austria.
Cancers (Basel) ; 15(5)2023 Mar 06.
Article em En | MEDLINE | ID: mdl-36900410
OBJECTIVES: To externally validate and assess the accuracy of a previously trained fully automatic nnU-Net CNN algorithm to identify and segment primary neuroblastoma tumors in MR images in a large children cohort. METHODS: An international multicenter, multivendor imaging repository of patients with neuroblastic tumors was used to validate the performance of a trained Machine Learning (ML) tool to identify and delineate primary neuroblastoma tumors. The dataset was heterogeneous and completely independent from the one used to train and tune the model, consisting of 300 children with neuroblastic tumors having 535 MR T2-weighted sequences (486 sequences at diagnosis and 49 after finalization of the first phase of chemotherapy). The automatic segmentation algorithm was based on a nnU-Net architecture developed within the PRIMAGE project. For comparison, the segmentation masks were manually edited by an expert radiologist, and the time for the manual editing was recorded. Different overlaps and spatial metrics were calculated to compare both masks. RESULTS: The median Dice Similarity Coefficient (DSC) was high 0.997; 0.944-1.000 (median; Q1-Q3). In 18 MR sequences (6%), the net was not able neither to identify nor segment the tumor. No differences were found regarding the MR magnetic field, type of T2 sequence, or tumor location. No significant differences in the performance of the net were found in patients with an MR performed after chemotherapy. The time for visual inspection of the generated masks was 7.9 ± 7.5 (mean ± Standard Deviation (SD)) seconds. Those cases where manual editing was needed (136 masks) required 124 ± 120 s. CONCLUSIONS: The automatic CNN was able to locate and segment the primary tumor on the T2-weighted images in 94% of cases. There was an extremely high agreement between the automatic tool and the manually edited masks. This is the first study to validate an automatic segmentation model for neuroblastic tumor identification and segmentation with body MR images. The semi-automatic approach with minor manual editing of the deep learning segmentation increases the radiologist's confidence in the solution with a minor workload for the radiologist.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article